IGF1 and acromegaly: Clinicians should consider performing comprehensive cardiovascular assessments for acromegaly patients with IGF-1 levels above this threshold to mitigate the risk of adverse cardiovascular outcomes, and close monitoring of these patients is recommended to manage potential complications effectively.